When NNMT is active, it slows fat breakdown, making your body use energy less efficiently
Activation of these receptors in the brain (particularly brainstem and hypothalamic regions) suppresses appetite, reduces food intake through both homeostatic and hedonic pathways, slows gastric emptying to prolong fullness, and inhibits postprandial glucagon release to aid glucose control
[3] [4] Clinical trials have demonstrated substantial reductions in hemoglobin A1c (up to 2.5% reduction from baseline) and body weight (up to 20% reduction from baseline) in the SURPASS and SURMOUNT clinical trial programs
Hepatitis, alcohol abuse, and fatty liver disease all damage the cells of the liver
GLP-1 therapy also slows the digestive process, allowing more gradual absorption of food
Extreme acid or alkaline conditions massively accelerate hydrolysis and should never be used for storage